Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
Products
Antibodies
ELISA and Assay Kits
Research Areas
Infectious Disease
Resources
Purchasing
Reference Material
Contact Us
Locations
Orders Processing,
Shipping & Receiving,
Warehouse
2 Shaker Rd Suites
B001/B101
Shirley, MA 01464
Production Lab
Floor 6, Suite 620
20700 44th Avenue W
Lynnwood, WA 98036
Telephone Numbers
Tel: +1 (206) 374-1102
Fax: +1 (206) 577-4565
Contact Us
Additional Contact Details
Login
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Forgot password?
Registration enables users to use special features of this website, such as past
order histories, retained contact details for faster checkout, review submissions, and special promotions.
order histories, retained contact details for faster checkout, review submissions, and special promotions.
Quick Order
BMP2
bone morphogenetic protein 2
BMP2 belongs to the transforming growth factor-beta (TGFB) superfamily. Bone morphogenic protein induces bone formation. BMP2 is a candidate gene for the autosomal dominant disease of fibrodysplasia (myositis) ossificans progressiva.
| Gene Name: | bone morphogenetic protein 2 |
| Family/Subfamily: | TGF beta , not assigned-TGF beta |
| Synonyms: | BMP2, BDA2, BMP-2, BMP-2A, BMP2A, Bone morphogenetic protein 2, Bone morphogenetic protein 2A |
| Target Sequences: | NM_001200 NP_001191.1 P12643 |
Publications (7)
1
Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases. Handlogten ME, Huang C, Shiraishi N, Awata H, Miller RT. The Prostate. 2013 (IHC-P; Human)
[PubMed:23334979]
2
Senataxin Mutation Reveals How R-Loops Promote Transcription by Blocking DNA Methylation at Gene Promoters. Grunseich C, Wang IX, Watts JA, Burdick JT, Guber RD, Zhu Z, Bruzel A, Lanman T, Chen K, Schindler AB, Edwards N, Ray-Chaudhury A, Yao J, Lehky T, Piszczek G, Crain B, Fischbeck KH, Cheung VG. Molecular cell. 2018 February;69:426-437. [Full Text Article]
[PubMed:29395064]
[PMC:PMC5815878]
Related Antibodies: LS-B12549.
3
Laminin differentially regulates the stemness of type I and type II pericytes. Gautam J, Nirwane A, Yao Y. Stem cell research & therapy. 2017 February;8:28. [Full Text Article]
[PubMed:28173861]
[PMC:PMC5297126]
☰ Filters
Products
Proteins
(32)
Type
Over-Expression Lysate
(2)
Recombinant
(30)
Target
BMP2
(32)
Format
Animal-free
(1)
Publications
No
(32)
Tag
6His-SUMO, N-terminus
(1)
Fc, C-terminus
(1)
GST
(1)
GST, N-terminus
(2)
His
(8)
His, N-Terminal
(1)
His-GST
(1)
His-T7
(2)
Human Mutant IgG1 Fc
(1)
Myc-DDK (Flag)
(2)
Species
Bovine
(1)
Dog
(2)
Human
(23)
Mouse
(1)
Pig
(2)
Rabbit
(1)
Rat
(1)
Source
293T Cells
(1)
CHO Cells
(2)
E. coli
(24)
HEK 293 Cells
(2)
Wheat Germ Extract
(3)
Purification
Purified
(8)
Low Endotoxin Level
Low endotoxin level
(12)
Biologically Active
Biologically active
(7)
Animal-free
Animal-free
(1)
E. coli
His
Less than 0.1 EU/µg protein (determined by LAL method).
50 µg/$587; 10 µg/$337
E. coli
His-GST
44.6 kDa
10 µg/$280; 50 µg/$435; 100 µg/$695; 200 µg/$870; 1 mg/$1,972; 500 µg/$1,514; 5 mg/$3,039; 2 mg/$2,159
E. coli
6His-SUMO, N-terminus
28.9 kDa
20 µg/$323; 1 mg/$1,355; 100 µg/$420
CHO Cells
None
Biologically active
26 kDa or 28-29 kDa
10 µg/$349; 2 µg/$268
E. coli
None
Less than 0.1 EU/µg protein (determined by LAL method).
13 kDa
20 µg/$677
E. coli
His, N-Terminal
42.4 kDa
50 µg/$419
E. coli
None
Biologically active
Less than 1.0 EU/µg protein (determined by LAL method).
26 kDa (SDS-PAGE)
50 µg/$470; 10 µg/$296; 1 mg/$2,064
Wheat Germ Extract
GST
70.51 kDa
2 µg/$439
293T Cells
Myc-DDK (Flag)
44.63 kDa
20 µg/$150
Wheat Germ Extract
GST, N-terminus
10 µg/$479; 25 µg/$670
Wheat Germ Extract
GST, N-terminus
10 µg/$479; 25 µg/$670
HEK 293 Cells
Myc-DDK (Flag)
44.63 kDa
100 µg/$494
CHO Cells
Human Mutant IgG1 Fc
Less than 0.06 EU/µg protein (determined by LAL method).
50 µg/$498
E. coli
None
Biologically active
26.0 kDa
10 µg/$388; 100 µg/$1,186; 500 µg/$2,269
E. coli
None
Biologically active
Less than 0.1 ng/µg of protein (less than 1EU/µg).
26.0 kDa
2 µg/$268; 10 µg/$349
E. coli
None
Biologically active
Less than 0.01 ng/µg of protein (Less than 0.1 EU/µg).
2 µg/$281; 10 µg/$369
E. coli
None
Biologically active
Less than 1.0 EU/µg protein (determined by LAL method).
250 µg/$739; 50 µg/$361
E. coli
None
13 kDa
20 µg/$485; 100 µg/$918
HEK 293 Cells
Fc, C-terminus
Less than 1.0 EU/µg protein (determined by LAL method).
39.5 kDa
20 µg/$430; 100 µg/$907
E. coli
None
Less than 1.0 EU/µg protein (determined by LAL method).
100 µg/$361; 500 µg/$739; 20 µg/$261
E. coli
None
Less than 1.0 EU/µg protein (determined by LAL method).
13.3 kDa
20 µg/$360; 100 µg/$728
E. coli
None
Less than 1.0 EU/µg protein (determined by LAL method).
13.3kD
10 µg/$321; 50 µg/$534; 500 µg/$1,815; 1 mg/$2,588
E. coli
None
Biologically active
Less than 1.0 EU/µg protein (determined by LAL method).
~26 kDa
10 µg/$395; 1 mg/$6,427
E. coli
His
16.7 kDa
10 µg/$292; 50 µg/$512; 100 µg/$817; 200 µg/$1,018; 1 mg/$2,168; 500 µg/$1,690; 5 mg/$3,571; 2 mg/$2,359
E. coli
His-T7
46.2 kDa
10 µg/$287; 50 µg/$482; 100 µg/$770; 200 µg/$962; 1 mg/$2,094; 500 µg/$1,623; 5 mg/$3,361; 2 mg/$2,284
Viewing 1-25
of 32
product results
If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.
